SBC Medical Group Holdings Incorporated Deferred Tax Assets, Net of Valuation Allowance
SBC Medical Group Holdings Incorporated (SBC) had Deferred Tax Assets, Net of Valuation Allowance of $9.97 million as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2026-03-27
- 2025-12-31: Deferred Tax Assets, Net of Valuation Allowance $9.97M.
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $15.65M.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $5.39M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2025-12-31 | $9.97M 10-K · filed 2026-03-27 |
| 2024-12-31 | $15.65M 10-K · filed 2026-03-27 |
| 2023-12-31 | $5.39M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |